Picture of Inotiv logo

NOTV Inotiv Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Annual income statement for Inotiv, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

C2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue43.660.589.6548572
Cost of Revenue
Gross Profit1418.230.2157165
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses43.863.595.2811654
Operating Profit-0.153-3.06-5.62-263-81.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.786-4.546.12-352-124
Provision for Income Taxes
Net Income After Taxes-0.79-4.6810.9-337-105
Minority Interest
Net Income Before Extraordinary Items
Net Income-0.79-4.6810.9-337-105
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.79-4.6810.9-337-105
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.076-0.4320.786-6.11-2.1